Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NAPA 250 SUPPOSITORY 250 MG - HSA Drug Approval Details

Approvals/HSA/NAPA 250 SUPPOSITORY 250 MG

Approved

THERAPEUTIC

NAPA 250 SUPPOSITORY 250 MG

BEXIMCO PHARMACEUTICALS LTD (BANGLADESH)🇸🇬 Health Sciences Authority

Approval Date: Dec 8, 1998
Approval ID: 61c5e335eccc0e28
Company: BEXIMCO PHARMACEUTICALS LTD (BANGLADESH)
Type: Therapeutic

Approval Details

Approval Id: 61c5e335eccc0e28
Drug Name: NAPA 250 SUPPOSITORY 250 MG
Product Name: NAPA 250 SUPPOSITORY 250 MG
Approval Number: SIN10522P
Approval Date: 1998-12-08
Registrant: PHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence Holder: PHARMATECH MEDICAL ENTERPRISE PTE LTD
Drug Type: Therapeutic
Forensic Classification: GENERAL SALE LIST
Dosage Form: SUPPOSITORY
Route Of Administration: RECTAL
Atc Code: N02BE01
Atc Item Name: paracetamol
Pharma Manufacturer Name: PHARMATECH MEDICAL ENTERPRISE PTE. LTD.
Company Detail Path: /organization/pharmatech-medical-enterprise-pte-ltd

Active Ingredients

PARACETAMOL

250 mg

PARACETAMOL

250 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Dec 8, 1998

Approval ID

61c5e335eccc0e28

Type

Therapeutic

Back to HSA Approvals